EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dual SIRPα / CD47 Blockade Potentiates Monocyte-Driven Clearance of MCF-7 Breast Cancer Cells

Iman Saffah Kareem, Ban Jasim Mohamad

Archives of Breast Cancer · 25.07.2026 · 13 (3) · 318-327

DOI: 10.32768/abc.3175948261-405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Breast Cancer, online erschienen am 25.07.2026. Verfasst von Iman Saffah Kareem und 1 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer (BC) is the most common cancer and a major cause of cancer-related death among women worldwide. In Iraq, it is the most prevalent malignancy in females. BC cells evade immune destruction through overexpression of CD47, a “don’t-eat-me” signal that binds SIRPα on monocytes and macrophages to inhibit phagocytosis. This study investigates CD47 inhibition in MCF-7 breast cancer cells and evaluates whether simultaneous SIRPα blockade enhances immune-mediated responses. It aims to assess the potential of treating MCF-7 cells in vitro by blocking the CD47–SIRPα interaction. To our knowledge, this is the first study in Iraq to examine CD47 and SIRPα expression and their therapeutic potential in breast cancer cell lines.

Methods

MCF-7 cells were cultured and treated with anti-CD47 antibodies with or without monocytes pre-incubated with anti-SIRPα. Cell morphology was assessed using inverted microscopy. CD47 expression in MCF-7 cells and SIRPα in monocytes was confirmed by immunocytochemistry (ICC). Cell viability was measured using the MTT assay. Statistical analysis was performed using ANOVA with Tukey’s post-hoc test.

Results

ICC confirmed high expression of CD47 in MCF-7 cells and SIRPα in monocytes. Combined anti-CD47 and anti-SIRPα treatment showed a trend toward greater reduction in cell viability compared to single treatments, although not statistically significant. Anti-CD47 alone reduced cell viability by 47%, likely due to indirect or antibody-mediated effects. Morphological changes included cell shrinkage and loss of adhesion.

Conclusion

Dual blockade of CD47 and SIRPα showed a trend toward enhanced monocyte-mediated reduction in MCF-7 cell viability, suggesting the CD47/SIRPα axis as a potential immunotherapeutic target requiring further validation.

Zitieren

APA

Kareem, I. S., & Mohamad, B. J. (2026). Dual SIRPα / CD47 Blockade Potentiates Monocyte-Driven Clearance of MCF-7 Breast Cancer Cells. Archives of Breast Cancer, 13(3), 318-327. https://doi.org/10.32768/abc.3175948261-405

Vancouver

Kareem IS, Mohamad BJ. Dual SIRPα / CD47 Blockade Potentiates Monocyte-Driven Clearance of MCF-7 Breast Cancer Cells. Archives of Breast Cancer. 2026;13(3):318-327. doi:10.32768/abc.3175948261-405

BibTeX
@article{Kareem2026,
  author = {Kareem, Iman Saffah and Mohamad, Ban Jasim},
  title = {Dual SIRPα / CD47 Blockade Potentiates Monocyte-Driven Clearance of MCF-7 Breast Cancer Cells},
  journal = {Archives of Breast Cancer},
  year = {2026},
  volume = {13},
  number = {3},
  pages = {318--327},
  doi = {10.32768/abc.3175948261-405}
}
Kostenlos starten →